170 related articles for article (PubMed ID: 27768596)
1. Elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin-conducted iron egress.
Jiang X; Zhang C; Qi S; Guo S; Chen Y; Du E; Zhang H; Wang X; Liu R; Qiao B; Yang K; Zhang Z; Xu Y
Oncotarget; 2016 Dec; 7(51):84893-84906. PubMed ID: 27768596
[TBL] [Abstract][Full Text] [Related]
2. Myeloid zinc-finger 1 (MZF-1) suppresses prostate tumor growth through enforcing ferroportin-conducted iron egress.
Chen Y; Zhang Z; Yang K; Du J; Xu Y; Liu S
Oncogene; 2015 Jul; 34(29):3839-47. PubMed ID: 25284586
[TBL] [Abstract][Full Text] [Related]
3. Effects of Ferroportin-Mediated Iron Depletion in Cells Representative of Different Histological Subtypes of Prostate Cancer.
Deng Z; Manz DH; Torti SV; Torti FM
Antioxid Redox Signal; 2019 Mar; 30(8):1043-1061. PubMed ID: 29061069
[TBL] [Abstract][Full Text] [Related]
4. Disordered signaling governing ferroportin transcription favors breast cancer growth.
Chen Y; Zhang S; Wang X; Guo W; Wang L; Zhang D; Yuan L; Zhang Z; Xu Y; Liu S
Cell Signal; 2015 Jan; 27(1):168-76. PubMed ID: 25451081
[TBL] [Abstract][Full Text] [Related]
5. Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
Tao T; Chen M; Jiang R; Guan H; Huang Y; Su H; Hu Q; Han X; Xiao J
Oncol Rep; 2017 Mar; 37(3):1430-1436. PubMed ID: 28184935
[TBL] [Abstract][Full Text] [Related]
6. Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin.
Xue D; Zhou C; Shi Y; Lu H; Xu R; He X
Oncotarget; 2016 Nov; 7(48):78804-78812. PubMed ID: 27788496
[TBL] [Abstract][Full Text] [Related]
7. GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression.
Jiang X; Chen Y; Du E; Yang K; Zhang Z; Qi S; Xu Y
Cell Signal; 2016 Sep; 28(9):1216-1224. PubMed ID: 27267060
[TBL] [Abstract][Full Text] [Related]
8. Estrogen contributes to regulating iron metabolism through governing ferroportin signaling via an estrogen response element.
Qian Y; Yin C; Chen Y; Zhang S; Jiang L; Wang F; Zhao M; Liu S
Cell Signal; 2015 May; 27(5):934-42. PubMed ID: 25660146
[TBL] [Abstract][Full Text] [Related]
9. The ZNF217 oncogene is a candidate organizer of repressive histone modifiers.
Banck MS; Li S; Nishio H; Wang C; Beutler AS; Walsh MJ
Epigenetics; 2009 Feb; 4(2):100-6. PubMed ID: 19242095
[TBL] [Abstract][Full Text] [Related]
10. Effect of ferroportin polymorphism on iron homeostasis and infection.
Kasvosve I
Clin Chim Acta; 2013 Feb; 416():20-5. PubMed ID: 23178444
[TBL] [Abstract][Full Text] [Related]
11. Identification of ZNF217, hnRNP-K, VEGF-A and IPO7 as targets for microRNAs that are downregulated in prostate carcinoma.
Szczyrba J; Nolte E; Hart M; Döll C; Wach S; Taubert H; Keck B; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
Int J Cancer; 2013 Feb; 132(4):775-84. PubMed ID: 22815235
[TBL] [Abstract][Full Text] [Related]
12. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
[TBL] [Abstract][Full Text] [Related]
13. Yin Yang 1-mediated epigenetic silencing of tumour-suppressive microRNAs activates nuclear factor-κB in hepatocellular carcinoma.
Tsang DP; Wu WK; Kang W; Lee YY; Wu F; Yu Z; Xiong L; Chan AW; Tong JH; Yang W; Li MS; Lau SS; Li X; Lee SD; Yang Y; Lai PB; Yu DY; Xu G; Lo KW; Chan MT; Wang H; Lee TL; Yu J; Wong N; Yip KY; To KF; Cheng AS
J Pathol; 2016 Apr; 238(5):651-64. PubMed ID: 26800240
[TBL] [Abstract][Full Text] [Related]
14. Cell-specific regulation of Ferroportin transcription following experimentally-induced acute anemia in mice.
Chiabrando D; Fiorito V; Marro S; Silengo L; Altruda F; Tolosano E
Blood Cells Mol Dis; 2013 Jan; 50(1):25-30. PubMed ID: 22921471
[TBL] [Abstract][Full Text] [Related]
15. E4BP4 promotes thyroid cancer proliferation by modulating iron homeostasis through repression of hepcidin.
Zhou Q; Chen J; Feng J; Wang J
Cell Death Dis; 2018 Sep; 9(10):987. PubMed ID: 30250199
[TBL] [Abstract][Full Text] [Related]
16. An important role of the hepcidin-ferroportin signaling in affecting tumor growth and metastasis.
Guo W; Zhang S; Chen Y; Zhang D; Yuan L; Cong H; Liu S
Acta Biochim Biophys Sin (Shanghai); 2015 Sep; 47(9):703-15. PubMed ID: 26201356
[TBL] [Abstract][Full Text] [Related]
17. RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation.
Jiang L; Wang J; Wang K; Wang H; Wu Q; Yang C; Yu Y; Ni P; Zhong Y; Song Z; Xie E; Hu R; Min J; Wang F
Blood; 2021 Aug; 138(8):689-705. PubMed ID: 33895792
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of ferroportin accelerates erastin-induced ferroptosis in neuroblastoma cells.
Geng N; Shi BJ; Li SL; Zhong ZY; Li YC; Xua WL; Zhou H; Cai JH
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3826-3836. PubMed ID: 29949159
[TBL] [Abstract][Full Text] [Related]
19. Evidence for dimerization of ferroportin in a human hepatic cell line using proximity ligation assays.
Rishi G; Secondes ES; Wallace DF; Subramaniam VN
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32301493
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic Suppression of SERPINB1 Promotes Inflammation-Mediated Prostate Cancer Progression.
Lerman I; Ma X; Seger C; Maolake A; Garcia-Hernandez ML; Rangel-Moreno J; Ackerman J; Nastiuk KL; Susiarjo M; Hammes SR
Mol Cancer Res; 2019 Apr; 17(4):845-859. PubMed ID: 30610107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]